What is the primary therapeutic goal of treating chronic hepatitis C infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

The Primary Goal of Chronic Hepatitis C Treatment is Viral Eradication

The treatment of chronic hepatitis C aims at eradication of the virus (Answer A). The primary therapeutic goal is to achieve a sustained virological response (SVR), defined as undetectable HCV RNA after treatment completion, which represents a cure of the infection 1, 2.

Why Eradication is the Goal

The rationale for viral eradication rather than mere suppression or reduction is compelling:

  • SVR equals cure: An SVR corresponds to permanent eradication of HCV infection, with late relapse occurring in less than 0.2% of cases beyond 6 months of follow-up 1
  • Mortality benefit: Eradicating HCV infection results in reduced rates of all-cause mortality across all stages of fibrosis 2, 3
  • Prevention of liver complications: SVR significantly reduces (though does not eliminate) the risk of hepatocellular carcinoma, cirrhosis, hepatic decompensation, and liver-related mortality 1, 2
  • Extrahepatic benefits: Successful eradication improves cryoglobulinemic vasculitis, HCV-related lymphoproliferative disorders, and overall quality of life 2

Why the Other Options Are Incorrect

Option B (Suppression) and Option C (Reduction of viremia) represent outdated concepts from earlier treatment eras. Modern direct-acting antiviral (DAA) regimens achieve >95% cure rates 2, making suppression an inadequate goal.

Option D (Elimination of anti-HCV antibodies) is neither achievable nor desirable—antibodies persist after viral clearance and do not indicate active infection 1.

Option E (Reduction of transmissibility) is a secondary public health benefit of achieving SVR, not the primary therapeutic goal 2.

Clinical Implementation

Current guidelines recommend:

  • Universal treatment: Antiviral treatment is recommended for all adults with acute or chronic HCV infection, except those with short life expectancy that cannot be remediated 2
  • Treatment target: Undetectable HCV RNA at 12-24 weeks post-treatment defines successful eradication 1, 4
  • Modern DAA regimens: Pangenotypic, coformulated regimens cure >95% of patients with relatively short treatment durations 2

The emphasis on complete viral eradication rather than viral suppression distinguishes hepatitis C treatment from conditions like HIV, where lifelong suppression is the goal. With hepatitis C, cure is achievable and should be the standard objective.

References

Related Questions

What are the criteria for starting antiviral therapy in adult patients with chronic hepatitis C, including genotype, disease stage, renal function, and contraindications?
What are the recommended management guidelines for an adult patient with chronic hepatitis C infection?
Can a person be infected with hepatitis C more than once?
In a patient with chronic hepatitis C and a newly identified suspicious hepatic lesion, should antiviral treatment be initiated before evaluating the mass, or should the lesion be investigated first?
Should chronic hepatitis C be treated in a critically ill patient?
In a patient with highly resistant type 2 diabetes receiving total parenteral nutrition (TPN) containing 300 g dextrose and 135 units of regular insulin (insulin sensitivity factor 10 mg/dL per unit) administered from 8 pm to 8 am, with blood glucose values of 192 mg/dL at 9 pm, 256 mg/dL at midnight, and 231 mg/dL at 4 am, how many additional units of regular insulin should be added to the TPN infusion?
Can colchicine be used together with ibuprofen and paracetamol in an elderly male post‑prostate surgery with adequate renal function?
What is the recommended acute management and subsequent evaluation for a 3-year-old with new‑onset afebrile seizures (posturing, limb rigidity, fixed gaze, drooling), prior neonatal hyperinsulinemia resolved at age 1, multiple episodes within 30 minutes, negative head CT and unremarkable labs?
How should I evaluate and manage a patient’s nutritional status and inflammatory burden instead of relying solely on serum albumin?
What is the recommended colchicine dosing schedule for an elderly male post‑prostate surgery with adequate renal function who is also taking ibuprofen and paracetamol for an acute gout flare?
What is the recommended evaluation and management for a spreading rash that is not responding to antihistamines and systemic steroids?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.